Skip to main content Back to Top
Advertisement

Using a Patient-Tailored Pharmacist Interventions to Improve Specialty Medication Adherence: A Pragmatic Randomized Controlled Trial

Broadcast Date: June 6, 2022

 

Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

This podcast will discuss results from a recently completed pragmatic, prospective, randomized controlled study evaluating a patient-tailored intervention to improve specialty medication adherence. Listeners will learn how this rigorous study design was executed and the significant impact it had on patient outcomes.

SPEAKERS

Amanda KibbonsAmanda Kibbons, PharmD, is a clinical pharmacist at Vanderbilt University Medical Center’s specialty pharmacy. She graduated from the University of Tennessee Health Science Center in 2007. She gained experience in both retail and inpatient pharmacy before joining Vanderbilt in 2018. She currently works in a multitude of specialty clinics assisting in medication management and patient access to specialty medications. In addition to her clinical work, she participates in outcomes research with a focus in medication adherence.

Autumn ZuckermanAutumn Zuckerman, PharmD, BCPS, AAHIVP, CSP is the director of health outcomes and research at Vanderbilt Specialty Pharmacy, and an affiliate professor at University of Tennessee College of Health Sciences, Lipscomb University College of Pharmacy, and Belmont University College of Pharmacy. Dr. Zuckerman received her Doctor of Pharmacy from Samford University McWhorter School of Pharmacy, then completed two years of residency training at the Tennessee Valley Healthcare System VA, specializing in ambulatory care.

 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.